133
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study

ORCID Icon &
Pages 1519-1525 | Published online: 09 Sep 2019

References

  • Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
  • Chen W, Zheng R, Zeng H, Zhang S. The incidence and mortality of major cancers in China, 2012. Chin J Cancer. 2016;35:73. doi:10.1186/s40880-016-0137-827484217
  • NCCN. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Breast Cancer Version 1, 2017. National Comprehensive Cancer Net work (NCCN). NCCN Clinical practice guidelines in oncology: breast cancer version 4, 2017 [EB/OL]. 11 5, 2017 Available from: http://www.nccn.org. Accessed 829, 2019.
  • Saha P, Regan MM, Pagani O, et al. Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy trials. J Clin Oncol. 2017;35(27):3113–3122. doi:10.1200/JCO.2016.72.094628654365
  • Petrie KJ, Weinman J, Sharpe N, et al. Predicting return to work and functioning following myocardial infarction: the role of the patient’s view of their illness. Br Med J. 1996;12:1191–1194. doi:10.1136/bmj.312.7040.1191
  • Julia R, Alan J, Janet S, et al. Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research. J Cancer Surviv. 2014;8:521–531. doi:10.1007/s11764-014-0374-224986227
  • Grunfeld EA, Hunter MS, Sikka P, et al. Adherence beliefs among breast cancer survivors taking tamoxifen. Patient Educ Couns. 2005;59:97–102. doi:10.1016/j.pec.2004.10.00516198223
  • Wouters H, Geffen ECG, Baas-Thijssen MC, et al. Disentangling breast cancer survivors’ perceptions and experiences with regard to endocrine therapy: nature and relevance for nonadherence. Breast. 2013;22:661–666. doi:10.1016/j.breast.2013.05.00523770134
  • Pan Y, Heisig SR, Blanckenburg P, et al. Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-yearprospective study. Breast Cancer Res Treat. 2018;168:667–677. doi:10.1007/s10549-017-4637-229330625
  • Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2004;22(16):3309–3315. doi:10.1200/JCO.2004.11.06415310774
  • Park CL, Waddington E, Abraham R. Different dimensions of religiousness/spirituality are associated with health behaviors in breast cancer survivors. Psychooncology. 2018;27(10):2466–2472. doi:10.1002/pon.485230092113
  • Hulett JM, Armer JM, Leary E, et al. Religiousness, spirituality, and salivary cortisol in breast cancer survivorship: a pilot study. Cancer Nurs. 2018;41(2):166–175. doi:10.1097/NCC.000000000000047128151830
  • Brett J, Boulton M, Fenlon D, et al. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence. Patient Prefer Adherence. 2018;12:291–300. doi:10.2147/PPA.S14578429497284
  • Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Impact of fertility concerns on tamoxifen initiation and persistence. J Natl Cancer Inst. 2015;107(10):202. doi:10.1093/jnci/djv202
  • Partridge AH. Cancer survivorship and the young breast cancer patient: Addressing the important issues. Oncologist. 2013;18:e18–e20. doi:10.1634/theoncologist.2012-042123576479
  • Kort JD, Eisenberg ML, Millheiser LS, Westphal LM. Fertility issues in cancer survivorship. CA Cancer J Clin. 2014;64:118–134. doi:10.3322/caac.2120524604743